raav.sflt-1
Gene therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2011 (NCT01494805)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Vascular endothelial growth factor receptor 1Supplementation
FLT1 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- raav.sflt-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01494805 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2011 | Adverum Biotechnologies, Inc., Lions Eye Institute |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Adverum Biotechnologies, Inc. | For profit | 1 | 0 | 1 | 2011 |
| Lions Eye Institute | Academic/Hospital | 1 | 1 | 1 | 2011 |
2 organizations
Page 1 / 1